SLRX
Salarius Pharmaceuticals Inc. Common Stock
السعر في الوقت الحقيقي
مخطط الأسعار
المقاييس الرئيسية
مقاييس السوق
الافتتاح
$0.707
الأعلى
$0.707
الأدنى
$0.707
الحجم
0.07M
أساسيات الشركة
إحصاءات التداول
أخبار ذات صلة
Salarius Pharmaceuticals Merger Partner, Decoy Therapeutics, Announces its Novel Inhibitors Show Promising In Silico Activity Against Measles and Related Viruses
CAMBRIDGE, Mass. and HOUSTON, March 26, 2025 (GLOBE NEWSWIRE) -- Decoy Therapeutics Inc. (Decoy), a privately held preclinical biopharmaceutical company engineering the next generation of peptide-conjugate
Salarius Pharmaceuticals Reports 2024 Financial Results and Provides Business Update
Contemplated merger with Decoy Therapeutics progressing as planned; upon closing, combined company expected to accelerate clinical development of novel peptide conjugate therapeutics for treating respiratory viruses and
أسهم ذات صلة
PWUPW
PowerUp Acquisition Corp. Warrant
TRINI
Trinity Capital Inc. 7.875% Notes Due 2029
PDM
Piedmont Office Realty Trust Inc.
METC
Ramaco Resources Inc.
GODN
Golden Star Acquisition Corporation Ordinary Shares
ابق على اطلاع
تعيين تنبيهات الأسعار، الحصول على تحديثات تحليل الذكاء الاصطناعي وأخبار السوق في الوقت الحقيقي.